Overview
Exstrophy-epispadias complex (EEC) is a spectrum of rare congenital malformations affecting the urinary tract, genitalia, musculoskeletal system, and sometimes the intestinal tract. The spectrum ranges in severity from epispadias (the mildest form, involving an abnormal opening of the urethra) to classic bladder exstrophy (where the bladder is open and exposed on the outside of the abdominal wall) to cloacal exstrophy (the most severe form, involving exposure of both the bladder and intestines along with other anomalies). The condition results from a defect in the closure of the lower abdominal wall during embryonic development, leading to abnormalities of the bladder, urethra, pelvic bones, pelvic floor muscles, and external genitalia. Key clinical features include an open bladder plate visible on the abdominal surface, widening (diastasis) of the pubic symphysis, epispadias, abnormalities of the external genitalia (such as a short or bifid penis in males, or a bifid clitoris in females), and inguinal hernias. In cloacal exstrophy, additional findings may include omphalocele, imperforate anus, and spinal anomalies. Affected individuals are at risk for urinary incontinence, vesicoureteral reflux, recurrent urinary tract infections, and renal complications if not properly managed. Treatment is primarily surgical and typically involves staged reconstructive procedures beginning in the neonatal period. The goals of surgery include closure of the bladder and abdominal wall, reconstruction of the genitalia and urethra, and ultimately achieving urinary continence. Modern staged repair or complete primary repair approaches have significantly improved outcomes, though many patients require multiple surgeries throughout childhood and into adulthood. Long-term multidisciplinary follow-up involving urology, orthopedics, nephrology, and psychosocial support is essential. Despite advances in surgical techniques, achieving full urinary continence remains a significant challenge, and some patients may require bladder augmentation or continent urinary diversion procedures.
Clinical phenotype terms— hover any for plain English:
Multifactorial
Caused by a mix of several genes and environmental factors
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
3 eventsNantes University Hospital — PHASE2
Alixer Nexgen Therapeutics Limited — PHASE2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Exstrophy-epispadias complex.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Exstrophy-epispadias complex at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Exstrophy-epispadias complex.
Community
No community posts yet. Be the first to share your experience with Exstrophy-epispadias complex.
Start the conversation →Latest news about Exstrophy-epispadias complex
Disease timeline:
New recruiting trial: A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure
A new clinical trial is recruiting patients for Exstrophy-epispadias complex
New recruiting trial: Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above
A new clinical trial is recruiting patients for Exstrophy-epispadias complex
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Exstrophy-epispadias complex
What is Exstrophy-epispadias complex?
Exstrophy-epispadias complex (EEC) is a spectrum of rare congenital malformations affecting the urinary tract, genitalia, musculoskeletal system, and sometimes the intestinal tract. The spectrum ranges in severity from epispadias (the mildest form, involving an abnormal opening of the urethra) to classic bladder exstrophy (where the bladder is open and exposed on the outside of the abdominal wall) to cloacal exstrophy (the most severe form, involving exposure of both the bladder and intestines along with other anomalies). The condition results from a defect in the closure of the lower abdomina
How is Exstrophy-epispadias complex inherited?
Exstrophy-epispadias complex follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Exstrophy-epispadias complex typically begin?
Typical onset of Exstrophy-epispadias complex is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Exstrophy-epispadias complex?
1 specialists and care centers treating Exstrophy-epispadias complex are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.